PMID- 38454161 OWN - NLM STAT- Publisher LR - 20240311 IS - 1476-5489 (Electronic) IS - 0955-9930 (Linking) DP - 2024 Mar 7 TI - Unveiling the molecular Hallmarks of Peyronie's disease: a comprehensive narrative review. LID - 10.1038/s41443-024-00845-2 [doi] AB - Peyronie's disease, a fibroinflammatory disorder, detrimentally impacts the sexual well-being of men and their partners. The manifestation of fibrotic plaques within penile tissue, attributed to dysregulated fibrogenesis, is pathognomonic for this condition. The onset of fibrosis hinges on the perturbation of the equilibrium between matrix metalloproteinases (MMPs), crucial enzymes governing the extracellular matrix, and tissue inhibitors of MMPs (TIMPs). In the context of Peyronie's disease, there is an elevation in TIMP levels coupled with a decline in MMP levels, culminating in fibrogenesis. Despite the scant molecular insights into fibrotic pathologies, particularly in the context of Peyronie's disease, a comprehensive literature search spanning 1995 to 2023, utilizing PubMed Library, was conducted to elucidate these mechanisms. The findings underscore the involvement of growth factors such as FGF and PDGF, and cytokines like IL-1 and IL-6, alongside PAI-1, PTX-3, HIF, and IgG4 in the fibrotic cascade. Given the tissue-specific modulation of fibrosis, comprehending the molecular underpinnings of penile fibrosis becomes imperative for the innovation of novel and efficacious therapies targeting Peyronie's disease. This review stands as a valuable resource for researchers and clinicians engaged in investigating the molecular basis of fibrotic diseases, offering guidance for advancements in understanding Peyronie's disease. CI - (c) 2024. The Author(s), under exclusive licence to Springer Nature Limited. FAU - Sahin, Ali AU - Sahin A AUID- ORCID: 0000-0002-3139-8205 AD - Selcuk University School of Medicine, 42250, Konya, Turkey. FAU - Babayev, Huseyn AU - Babayev H AD - Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, 7265, Davos, Switzerland. FAU - Cirigliano, Lorenzo AU - Cirigliano L AUID- ORCID: 0000-0002-8732-4272 AD - Department of Urology, Molinette Hospital, University of Torino, AOU Citta della Salute e della Scienza di Torino, Turin, Italy. FAU - Preto, Mirko AU - Preto M AUID- ORCID: 0000-0002-8144-6498 AD - Department of Urology, Molinette Hospital, University of Torino, AOU Citta della Salute e della Scienza di Torino, Turin, Italy. FAU - Falcone, Marco AU - Falcone M AUID- ORCID: 0000-0003-1101-892X AD - Department of Urology, Molinette Hospital, University of Torino, AOU Citta della Salute e della Scienza di Torino, Turin, Italy. FAU - Altintas, Emre AU - Altintas E AUID- ORCID: 0000-0002-6797-3937 AD - Department of Urology, Selcuk University School of Medicine, 42250, Konya, Turkey. FAU - Gul, Murat AU - Gul M AUID- ORCID: 0000-0002-6657-6227 AD - Department of Urology, Molinette Hospital, University of Torino, AOU Citta della Salute e della Scienza di Torino, Turin, Italy. drmuratgul@hotmail.com. AD - Department of Urology, Selcuk University School of Medicine, 42250, Konya, Turkey. drmuratgul@hotmail.com. LA - eng PT - Journal Article PT - Review DEP - 20240307 PL - England TA - Int J Impot Res JT - International journal of impotence research JID - 9007383 SB - IM EDAT- 2024/03/08 00:43 MHDA- 2024/03/08 00:43 CRDT- 2024/03/07 23:50 PHST- 2023/10/11 00:00 [received] PHST- 2024/02/12 00:00 [accepted] PHST- 2024/01/26 00:00 [revised] PHST- 2024/03/08 00:43 [pubmed] PHST- 2024/03/08 00:43 [medline] PHST- 2024/03/07 23:50 [entrez] AID - 10.1038/s41443-024-00845-2 [pii] AID - 10.1038/s41443-024-00845-2 [doi] PST - aheadofprint SO - Int J Impot Res. 2024 Mar 7. doi: 10.1038/s41443-024-00845-2.